150 related articles for article (PubMed ID: 23312772)
1. Revisiting bleomycin from pathophysiology to safe clinical use.
Froudarakis M; Hatzimichael E; Kyriazopoulou L; Lagos K; Pappas P; Tzakos AG; Karavasilis V; Daliani D; Papandreou C; Briasoulis E
Crit Rev Oncol Hematol; 2013 Jul; 87(1):90-100. PubMed ID: 23312772
[TBL] [Abstract][Full Text] [Related]
2. Incidence, outcome and predictors of bleomycin pulmonary toxicity in a university hospital in Oman.
Ahmed BM; Al-Zakwani IS
J Oncol Pharm Pract; 2013 Mar; 19(1):3-7. PubMed ID: 22504168
[TBL] [Abstract][Full Text] [Related]
3. Bleomycin induced flagellate erythema: Revisiting a unique complication.
Biswas A; Chaudhari PB; Sharma P; Singh L; Julka PK; Sethuraman G
J Cancer Res Ther; 2013; 9(3):500-3. PubMed ID: 24125992
[TBL] [Abstract][Full Text] [Related]
4. Pirfenidone as salvage treatment for refractory bleomycin-induced lung injury: a case report of seminoma.
Sakamoto K; Ito S; Hashimoto N; Hasegawa Y
BMC Cancer; 2017 Aug; 17(1):526. PubMed ID: 28784103
[TBL] [Abstract][Full Text] [Related]
5. Bleomycin-induced lung injury treated with venovenous extracorporeal membrane oxygenation (ECMO) and ultra-protective ventilator settings.
Odish MF; McGuire WC; Thistlethwaite P; Crotty Alexander LE
BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33229479
[TBL] [Abstract][Full Text] [Related]
6. More on bleomycin and scuba diving.
White RM
Neth J Med; 2003 Nov; 61(11):388-9; author reply 389. PubMed ID: 14768724
[No Abstract] [Full Text] [Related]
7. Bleomycin and the skin.
Yamamoto T
Br J Dermatol; 2006 Nov; 155(5):869-75. PubMed ID: 17034512
[TBL] [Abstract][Full Text] [Related]
8. Elevation of the erythrocyte sedimentation rate precedes exacerbation of bleomycin-induced pulmonary toxicity: report of two cases and review of literature.
Higa GM; AlKhouri N; Auber ML
Pharmacotherapy; 1997; 17(6):1315-21. PubMed ID: 9399618
[TBL] [Abstract][Full Text] [Related]
9. Bleomycin-induced pulmonary toxicity in chemotherapy for testicular cancer.
Kawai K; Akaza H
Expert Opin Drug Saf; 2003 Nov; 2(6):587-96. PubMed ID: 14585067
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of bleomycin-induced pneumonitis on the outcome of Hodgkin's lymphoma.
Ngeow J; Tan IB; Kanesvaran R; Tan HC; Tao M; Quek R; Lim ST
Ann Hematol; 2011 Jan; 90(1):67-72. PubMed ID: 20676640
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive assessment of bleomycin-induced lung injury and the effects of short-term glucocorticosteroid treatment in rats using MRI.
Babin AL; Cannet C; Gérard C; Wyss D; Page CP; Beckmann N
J Magn Reson Imaging; 2011 Mar; 33(3):603-14. PubMed ID: 21563244
[TBL] [Abstract][Full Text] [Related]
12. Development of a best-practice clinical guideline for the use of bleomycin in the treatment of germ cell tumours in the UK.
Watson RA; De La Peña H; Tsakok MT; Joseph J; Stoneham S; Shamash J; Joffe J; Mazhar D; Traill Z; Ho LP; Brand S; Protheroe AS
Br J Cancer; 2018 Oct; 119(9):1044-1051. PubMed ID: 30356125
[TBL] [Abstract][Full Text] [Related]
13. Bleomycin-induced "flagellate dermatitis".
Arseculeratne G; Berroeta L; Meiklejohn D; Mountain RE; Ryan JC; Spinou C; Das SN; Evans AT; Lowe JG
Arch Dermatol; 2007 Nov; 143(11):1461-2. PubMed ID: 18025386
[No Abstract] [Full Text] [Related]
14. Diffuse ground-glass opacities in a patient with Hodgkin lymphoma and progressive respiratory failure.
Godoy MC; Nonaka D; Raphael BG; Vlahos I
Chest; 2008 Jul; 134(1):207-12. PubMed ID: 18628228
[No Abstract] [Full Text] [Related]
15. Variants in
Thakkar DN; Prapath I; Adithan S; Ramasamy K; Selvarajan S; Dubashi B
Per Med; 2020 May; 17(3):203-212. PubMed ID: 32320335
[No Abstract] [Full Text] [Related]
16. [Apoptosis induced by bleomycin: influence of cellular models].
Brahim-Loghmari S; Kenani A
Arch Inst Pasteur Tunis; 2009; 86(1-4):15-25. PubMed ID: 20707217
[TBL] [Abstract][Full Text] [Related]
17. Bleomycin induced pulmonary toxicity in patients with germ cell tumours.
Usman M; Faruqui ZS; ud Din N; Zahid KF
J Ayub Med Coll Abbottabad; 2010; 22(3):35-7. PubMed ID: 22338413
[TBL] [Abstract][Full Text] [Related]
18. The Role of Hypertension and Renin-angiotensin-aldosterone System Inhibitors in Bleomycin-induced Lung Injury.
Hara R; Onizuka M; Shiraiwa S; Harada K; Aoyama Y; Ogiya D; Toyosaki M; Suzuki R; Machida S; Ohmachi K; Ogawa Y; Kawada H; Watanabe S; Miyajima A; Masuda R; Iwazaki M; Mikami M; Koike T; Mochizuki H; Ando K
Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):e321-e327. PubMed ID: 33127326
[TBL] [Abstract][Full Text] [Related]
19. [Consortium for detection and management of lung damage induced by bleomycin].
Biya J; Stoclin A; Dury S; Le Pavec J; Mir O; Lazarovici J; Fermé C; Annereau M; Ekpe K; Massard C; Michot JM
Bull Cancer; 2016; 103(7-8):651-61. PubMed ID: 27241272
[TBL] [Abstract][Full Text] [Related]
20. Combined prednisolone and pirfenidone in bleomycin-induced lung disease.
Vaidya PJ; Sandeepa HS; Singh T; Susheel Kumar SK; Bhargava R; Ramakrishnan G; Chhajed PN
J Cancer Res Ther; 2016; 12(3):1198-1202. PubMed ID: 28054535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
